Trials / Completed
CompletedNCT04542577
PMCF Study on the Safety and Performance of PROSPACE 3D / PROSPACE 3D OBLIQUE / TSPACE 3D
Multicenter PMCF Study on the Safety and Performance of PROSPACE 3D / PROSPACE 3D OBLIQUE / TSPACE 3D - A Prospective Study on Total Indications
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 208 (actual)
- Sponsor
- Aesculap AG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, pure data collection of all PROSPACE 3D, PROSPACE 3D Oblique, TSPACE 3D patients in selected centers (not interventional, multicenter
Detailed description
The study collects a data set for each patient receiving a PROSPACE 3D, PROSPACE 3D Oblique, or TSPACE 3D implant. It is intended to collect data preoperatively, intraoperatively and at one follow-up- assessment after a minimum of one year postoperatively containing * Basic medical history * Type of surgical procedure * Treated segments * Implant characteristics (including additional implants for anterior/posterior stabilization) * Scores: ODI, Pain (VAS), EQ-5D * Patient satisfaction
Conditions
Timeline
- Start date
- 2020-09-23
- Primary completion
- 2023-01-09
- Completion
- 2024-01-25
- First posted
- 2020-09-09
- Last updated
- 2024-12-18
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT04542577. Inclusion in this directory is not an endorsement.